 Raymond Estacio
Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 19 | 2025 | 2168 | 1.620 |
Why?
| | Community Health Services | 3 | 2017 | 233 | 0.830 |
Why?
| | Albuminuria | 7 | 2023 | 190 | 0.800 |
Why?
| | Diabetes Mellitus, Type 2 | 16 | 2025 | 2583 | 0.790 |
Why?
| | Health Promotion | 4 | 2023 | 774 | 0.660 |
Why?
| | Case Management | 2 | 2012 | 67 | 0.620 |
Why?
| | Hypertension | 9 | 2016 | 1263 | 0.600 |
Why?
| | Community Health Workers | 2 | 2025 | 87 | 0.550 |
Why?
| | Antihypertensive Agents | 7 | 2016 | 510 | 0.520 |
Why?
| | Program Evaluation | 3 | 2017 | 948 | 0.490 |
Why?
| | Renin-Angiotensin System | 2 | 2024 | 78 | 0.490 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2024 | 221 | 0.480 |
Why?
| | Primary Health Care | 4 | 2017 | 1733 | 0.470 |
Why?
| | Lipoproteins, LDL | 2 | 2017 | 119 | 0.470 |
Why?
| | Risk Reduction Behavior | 2 | 2017 | 226 | 0.440 |
Why?
| | Text Messaging | 2 | 2015 | 182 | 0.440 |
Why?
| | Glomerular Filtration Rate | 5 | 2024 | 760 | 0.410 |
Why?
| | Diabetes Mellitus | 3 | 2012 | 1098 | 0.400 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2024 | 653 | 0.380 |
Why?
| | Coronary Disease | 2 | 2012 | 383 | 0.360 |
Why?
| | Nursing Care | 1 | 2012 | 41 | 0.340 |
Why?
| | Colorado | 13 | 2025 | 4564 | 0.320 |
Why?
| | Patient Admission | 1 | 2012 | 218 | 0.310 |
Why?
| | Angiotensin Receptor Antagonists | 3 | 2024 | 114 | 0.300 |
Why?
| | Phosphorus | 1 | 2009 | 99 | 0.280 |
Why?
| | Randomized Controlled Trials as Topic | 6 | 2024 | 1720 | 0.280 |
Why?
| | Nursing Diagnosis | 1 | 2008 | 18 | 0.280 |
Why?
| | Blood Pressure | 7 | 2016 | 1769 | 0.280 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 885 | 0.270 |
Why?
| | Cardiac Output, Low | 1 | 2008 | 54 | 0.270 |
Why?
| | Heart Rate | 2 | 2011 | 855 | 0.260 |
Why?
| | Community-Institutional Relations | 1 | 2008 | 101 | 0.260 |
Why?
| | Drug Prescriptions | 1 | 2009 | 284 | 0.250 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 38 | 0.250 |
Why?
| | Tetrazoles | 1 | 2006 | 50 | 0.250 |
Why?
| | Valine | 1 | 2006 | 80 | 0.240 |
Why?
| | Middle Aged | 30 | 2025 | 35875 | 0.240 |
Why?
| | Risk Factors | 11 | 2023 | 10779 | 0.240 |
Why?
| | Drug Monitoring | 1 | 2009 | 395 | 0.230 |
Why?
| | Blood Pressure Determination | 2 | 2017 | 144 | 0.230 |
Why?
| | Aged | 21 | 2025 | 25913 | 0.230 |
Why?
| | Diabetic Nephropathies | 3 | 2006 | 318 | 0.210 |
Why?
| | Cohort Studies | 10 | 2012 | 5960 | 0.200 |
Why?
| | Lipids | 1 | 2008 | 710 | 0.190 |
Why?
| | Humans | 43 | 2025 | 144759 | 0.190 |
Why?
| | Telemedicine | 1 | 2012 | 945 | 0.180 |
Why?
| | Nisoldipine | 4 | 2009 | 7 | 0.180 |
Why?
| | Enalapril | 4 | 2009 | 16 | 0.180 |
Why?
| | Diabetic Angiopathies | 5 | 2007 | 263 | 0.170 |
Why?
| | Follow-Up Studies | 9 | 2012 | 5408 | 0.170 |
Why?
| | Medically Underserved Area | 2 | 2015 | 101 | 0.170 |
Why?
| | Adult | 17 | 2022 | 40449 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2023 | 168 | 0.160 |
Why?
| | Disease Progression | 3 | 2024 | 2847 | 0.160 |
Why?
| | Proportional Hazards Models | 5 | 2012 | 1325 | 0.160 |
Why?
| | Life Style | 3 | 2012 | 479 | 0.150 |
Why?
| | Male | 28 | 2025 | 72315 | 0.150 |
Why?
| | Female | 28 | 2025 | 78271 | 0.140 |
Why?
| | Self Care | 2 | 2012 | 389 | 0.140 |
Why?
| | Health Literacy | 1 | 2021 | 184 | 0.140 |
Why?
| | Healthy Lifestyle | 1 | 2017 | 37 | 0.130 |
Why?
| | Poverty | 3 | 2017 | 529 | 0.130 |
Why?
| | Pilot Projects | 3 | 2025 | 1886 | 0.120 |
Why?
| | Prospective Studies | 7 | 2012 | 7990 | 0.120 |
Why?
| | Exercise | 1 | 2008 | 2201 | 0.120 |
Why?
| | Urban Population | 2 | 2017 | 491 | 0.120 |
Why?
| | Diabetic Neuropathies | 3 | 2006 | 99 | 0.110 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 124 | 0.110 |
Why?
| | Educational Status | 1 | 2017 | 467 | 0.110 |
Why?
| | Triglycerides | 1 | 2017 | 520 | 0.110 |
Why?
| | Focus Groups | 2 | 2015 | 573 | 0.110 |
Why?
| | Rural Population | 2 | 2025 | 650 | 0.110 |
Why?
| | Accelerometry | 1 | 2015 | 119 | 0.100 |
Why?
| | Hyperlipidemias | 2 | 2005 | 122 | 0.100 |
Why?
| | Time Factors | 8 | 2024 | 7173 | 0.100 |
Why?
| | Rural Health Services | 1 | 2015 | 141 | 0.100 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 439 | 0.100 |
Why?
| | Risk Assessment | 4 | 2011 | 3671 | 0.090 |
Why?
| | Diabetic Retinopathy | 2 | 2006 | 208 | 0.090 |
Why?
| | Geographic Information Systems | 1 | 2011 | 46 | 0.090 |
Why?
| | Bayes Theorem | 2 | 2024 | 433 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2016 | 8265 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2012 | 129 | 0.080 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2008 | 3890 | 0.080 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 69 | 0.080 |
Why?
| | Guideline Adherence | 2 | 2007 | 589 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 588 | 0.080 |
Why?
| | Algorithms | 2 | 2008 | 1837 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 721 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2012 | 1560 | 0.080 |
Why?
| | Registries | 2 | 2009 | 2385 | 0.080 |
Why?
| | Fumarates | 1 | 2009 | 10 | 0.070 |
Why?
| | Renin | 1 | 2009 | 34 | 0.070 |
Why?
| | Myocardial Infarction | 3 | 2006 | 1209 | 0.070 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 2115 | 0.070 |
Why?
| | Health Maintenance Organizations | 1 | 2009 | 104 | 0.070 |
Why?
| | Urban Health Services | 1 | 2009 | 70 | 0.070 |
Why?
| | Kidney | 2 | 2024 | 1495 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2024 | 11679 | 0.070 |
Why?
| | Risk Management | 1 | 2009 | 84 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 634 | 0.070 |
Why?
| | Comorbidity | 3 | 2009 | 1658 | 0.070 |
Why?
| | Amides | 1 | 2009 | 101 | 0.070 |
Why?
| | Logistic Models | 3 | 2009 | 2117 | 0.070 |
Why?
| | Medical Errors | 1 | 2009 | 118 | 0.070 |
Why?
| | Diabetes Complications | 2 | 2009 | 222 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2009 | 1539 | 0.070 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1326 | 0.070 |
Why?
| | Minority Groups | 1 | 2010 | 282 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 95 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 645 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2024 | 17066 | 0.060 |
Why?
| | Motivation | 1 | 2012 | 610 | 0.060 |
Why?
| | Electrocardiography | 2 | 2008 | 662 | 0.060 |
Why?
| | Valsartan | 1 | 2006 | 32 | 0.060 |
Why?
| | Blood Glucose | 1 | 2017 | 2327 | 0.060 |
Why?
| | Young Adult | 2 | 2015 | 14105 | 0.060 |
Why?
| | Kidney Function Tests | 1 | 2006 | 157 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2015 | 1098 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2012 | 2947 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 836 | 0.060 |
Why?
| | Program Development | 1 | 2008 | 370 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 427 | 0.060 |
Why?
| | Stroke | 3 | 2003 | 1256 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 506 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2007 | 340 | 0.050 |
Why?
| | Survival Analysis | 1 | 2008 | 1382 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2006 | 283 | 0.050 |
Why?
| | Reagent Strips | 1 | 2004 | 8 | 0.050 |
Why?
| | Mass Screening | 1 | 2012 | 1347 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2024 | 100 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2012 | 1173 | 0.050 |
Why?
| | Calcium | 1 | 2009 | 1183 | 0.050 |
Why?
| | Peripheral Vascular Diseases | 1 | 2003 | 104 | 0.050 |
Why?
| | Incidence | 4 | 2011 | 2879 | 0.040 |
Why?
| | Research Design | 1 | 2008 | 1135 | 0.040 |
Why?
| | Heart Ventricles | 1 | 2006 | 760 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2005 | 780 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2024 | 462 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1472 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4282 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2024 | 704 | 0.030 |
Why?
| | Odds Ratio | 3 | 2005 | 1075 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2010 | 529 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 1387 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1694 | 0.030 |
Why?
| | Hospitals | 2 | 2009 | 730 | 0.020 |
Why?
| | Adolescent | 1 | 2012 | 22428 | 0.020 |
Why?
| | United States | 3 | 2021 | 15966 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4271 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 141 | 0.020 |
Why?
| | Heart Failure | 1 | 2004 | 2323 | 0.020 |
Why?
| | Information Dissemination | 1 | 2012 | 223 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 114 | 0.020 |
Why?
| | Medication Errors | 1 | 2009 | 83 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5868 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 614 | 0.020 |
Why?
| | Health Surveys | 1 | 2010 | 518 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 704 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 965 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 284 | 0.020 |
Why?
| | Medical Audit | 1 | 2007 | 77 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 251 | 0.020 |
Why?
| | Public Policy | 1 | 2006 | 79 | 0.010 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2012 | 699 | 0.010 |
Why?
| | Smoking Prevention | 1 | 2006 | 166 | 0.010 |
Why?
| | Smoke | 1 | 2006 | 148 | 0.010 |
Why?
| | Hospitalization | 2 | 2006 | 2433 | 0.010 |
Why?
| | Specific Gravity | 1 | 2004 | 11 | 0.010 |
Why?
| | Exercise Test | 1 | 2006 | 634 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2006 | 724 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1813 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 732 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 2089 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2003 | 333 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1414 | 0.010 |
Why?
| | Survivors | 1 | 2006 | 520 | 0.010 |
Why?
| | Hypolipidemic Agents | 1 | 2003 | 88 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2006 | 439 | 0.010 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 165 | 0.010 |
Why?
| | Age Factors | 1 | 2010 | 3333 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2002 | 312 | 0.010 |
Why?
| | Cholesterol, LDL | 1 | 2003 | 358 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2003 | 230 | 0.010 |
Why?
| | Internet | 1 | 2005 | 699 | 0.010 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 585 | 0.010 |
Why?
| | Patient Discharge | 1 | 2007 | 983 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2005 | 1053 | 0.010 |
Why?
| | Mental Disorders | 1 | 2008 | 1168 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 1094 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 2029 | 0.010 |
Why?
| | Body Mass Index | 1 | 2006 | 2438 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2003 | 741 | 0.010 |
Why?
|
|
Estacio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|